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In this perspective we describe examples of crosstalk between nuclear receptors (NRs) and Notch signaling
by means of direct functional interactions between components of both pathways.This crosstalk may provide
eukaryotic organisms with molecular mechanisms for the coordination of llong-distance endocrine signals
with cell-to-cell juxtacrine communication.
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Introduction
The ability of nuclear receptors (NRs) to regulate
transcription from target genes depends on the
recruitment of chromatin remodeling enzymes and the
transcription machinery. More than 100 different NR
co-regulators have been reported, many of which may
also mediate the function of other transcription factors.
The function of these proteins is subject to regulation at
several levels, including their rate of expression, protein
stability, postranslational modifications, changes in
subcellular localization, and allosteric modifications. In
addition, cross-coupling between different signaling
pathways may play an important role in creating the
myriad of responses required in higher eukaryotic
organisms. We have identified a novel mechanism of
crosstalk between the androgen receptor and Notch
signaling pathways with potential implications in the
development of prostate cancer. Our results, together
with recent reports describing other mechanisms of
crosstalk between NRs and Notch, suggest that these
two signaling pathways could have unexpected functional
interactions.
Characterization of HEY1, a mediator of
Notch signaling, as an androgen
receptor corepressor
SRC1 is a member of the p160 family of coactivators that
play a central role in the regulation of NR transcriptional
activity, interacting directly with them and acting as
platform for the recruitment of the enzymatic activities
responsible for the regulation of gene expression [Glass
and Rosenfeld, 2000; Leo and Chen, 2000; McKenna
and O'Malley, 2002; Onate et al., 1995]. In an attempt to
identify the protein interactions required for the regulation
of NR activity we performed a yeast two-hybrid screen
with the highly conserved bHLH-PAS N-terminal domain
of SRC1, a putative protein interaction region. One of the
proteins we found was later characterized as a
downstream target of Notch signaling pathways, named
HEY1(Hairy/Enhancer of split related with YRPW motif
1) a member of the bHLH-Orange domain superfamily of
transcriptional repressors [Davis and Turner, 2001; Iso
et al., 2003]. Although it was initially surprising to find an
interaction between a well characterized NR coactivator
and a transcriptional repressor, genetic and biochemical
evidences led us to study possible effects on androgen
receptor (AR) transcriptional activity.We found that HEY1
interacts directly with both SRC1 and the AR and
demonstrated that it could function as a repressor of AR
[Belandia et al., 2005]. None of the other steroid receptors
tested was repressed by HEY1 and, to our knowledge,
AR is the only NR inhibited by HEY1.
Eukaryotic transcriptional repressors can act in a passive
way, by forming inactive heterodimers with transcriptional
activators, by sequestering coactivators, or by competing
with positive transcription factors for DNA binding. On the
other hand, active transcriptional repressors possess
intrinsic repressing activities that recruit enzymatic
activities such as histone deacetylases (HDACs) and
ATP-dependent chromatin remodeling factors,
contributing to compact the chromatin fiber. HEY1 can
bind to E-box motifs in the DNA and it also contains at
least two independent domains with autonomous
repressing activity; a HDAC dependent C-terminal region,
and the N-terminal bHLH domain that represses through
both HDAC-dependent and HDAC-independent
mechanisms.The bHLH domain interacts with Sin3/NCoR
complexes that mediate the recruitment of HDACs,
non-covalent nucleosome remodeling complexes and
histone methytransferases. HEY1 mediated repression
of the AR requires the concerted action of both repressive
domains suggesting that the repression reflects a
combination of multiple repressing mechanisms.HEY1,
like other HEY and HES genes, is a target gene for Notch
signaling. Notch receptors are transmembrane proteins
that interact with their ligands present in the surface of
adjacent cells. Upon Notch ligand binding, the notch
intracellular domain migrates to the nucleus and induces
the expression of primary targets of Notch signaling, such
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as HEY and HES genes [Iso et al., 2003; Kadesch, 2004].
Increasing HEY1 expression blocks the ability of SRC1
to potentiate AR transcriptional activity, therefore,
changes in the expression of endogenous levels of HEY1
in the cell, induced by Notch activation, have the potential
to modulate the cellular responses to testosterone.
Is there a reciprocal negative feedback
between Notch and AR-dependent
pathways in the prostate?
Gene profiling experiments have identified a number of
signaling pathways, including notch signaling, that may
be subject to regulation by testosterone in the prostate
[Nantermet et al., 2003]. Thus NOTCH1 and its ligand
JAGGED1 were repressed and a negative regulator of
Notch signaling, SEL1L, was induced, indicating that
testosterone might inhibit Notch signaling.These results,
along with our observed repression of AR by HEY1, a
Notch target, provide a direct mechanism for reciprocal
negative feedback between androgen-dependent gene
regulation and Notch signaling (Figure 1). Accordingly,
this crosstalk could contribute to the coordination between
‘long-distance’ endocrine signaling exhibited by steroid
hormones, and cell-to-cell juxtacrine signals transmitted
by Notch receptors.
Figure 1.  Proposed mechanism for crosstalk between the
Androgen Receptor and Notch signaling pathways. The AR and
Notch receptors play essential roles in the regulation of prostate
development and homeostasis. Notch signaling initiates when
receptor-bearing cells interact with Notch ligands present in neighboring
cells. Notch activation causes an increase in HEY1 expression and HEY1
accumulates in the nucleus repressing AR transcriptional activity. In a
reciprocal way, the activation of AR upon androgen binding downregulates
the expression of Notch1 receptor and its ligand Jagged1, and upregulates
Sel1L, a negative regulator of Notch. These changes in gene expression
presumably will inhibit signal transmission via Notch receptors. This
crosstalk can help to modulate both pathways, integrating an endocrine
signal with cell-to-cell communication in a coordinate response.
Implications for prostate cancer
Recent reports demonstrated an important role for Notch
signaling in the regulation of normal prostate development
[Shou et al., 2001; Wang et al., 2004]. In addition, the
expression of NOTCH1 and its ligand JAGGED1 is
elevated in malignant prostatic epithelial cells and it has
been proposed that dysregulation of JAGGED1 plays a
role in prostate cancer progression and metastasis
[Santagata et al., 2004; Shou et al., 2001].We compared
HEY1 expression between human primary prostate
tumors and benign prostatic hyperplasia (BPH) and we
found a striking difference in the localization of HEY1
protein in malignant cells. The majority of BPH samples
showed strong nuclear HEY1 staining whereas its
expression was restricted to the cytoplasmic compartment
of prostate carcinoma cells (in 8 out 10 patients). The
nuclear exclusion of HEY1 did not affect AR expression,
which was localized mainly in epithelial cell nuclei in both
BPH and prostate cancer. Our proposed mechanism for
repression of AR-target genes via induction of Notch
signaling depends on the accumulation of HEY1 in the
nucleus, therefore its nuclear exclusion in cancer cells
would remove a brake for AR action. Thus, cancer cells
would become insensitive to Notch ligands and proliferate
despite contact inhibition signals received by Notch
receptors (Figure 2). In addition, other metabolic pathways
repressed by HEY1 might also be affected.
Figure 2.  Hypothetical model describing how alterations in HEY1
subcellular localization could contribute to an abnormal response
to androgens in prostate cancer cells. In normal cells, upon androgen
binding, AR binds to its cognate response elements in the promoter of
target genes and induces gene expression.The activation of Notch signals
in the same cells leads to the accumulation of the repressor HEY1 in the
nuclei, reducing the expression of AR-dependent genes. In cancer cells,
if HEY1 is excluded from the nuclei, it cannot repress AR action. Thus,
cancer cells are insensitive to AR modulation via Notch signals mediated
by HEY1.
We need to analyze more cancer samples before we can
generalize our observations, but our findings expand the
list of possible causes for the appearance of
androgen-independent prostate cancer. It will be of
interest to investigate nucleocytoplasmic shuttling in
cancer cells and determine whether defective
mechanisms arise that might be restricted to certain
signaling molecules that could offer a proliferative
advantage. The mechanisms that regulate HEY1
subcellular localization are still unknown. Sequence
analysis has identified several regions in HEY1
homologous to nuclear export and nuclear localization
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consensus signals and mutational studies of these regions
should give us clues regarding the mechanisms regulating
HEY1 transport within the cell. Prostate cells depend on
androgens for growth control and to avoid apoptosis,
therefore nearly all advanced androgen-independent
prostate tumors retain AR expression. Extensive research
has described many mechanisms that contribute to the
escape of AR to normal regulation, including mutations
in the AR, changes in its expression levels and/or its
coactivators or aberrant stimulation through crosstalk with
peptide growth factors and cytokines. Our results suggest
that it might be a selection for reduced HEY1 dependent
Notch signaling in prostate cancer. However, HEY1 is
only one of the many molecular components of the
complex cascades responsible for transmitting Notch
signals. Notch signaling can suppress or promote
tumorigenesis depending on the cellular context and the
crosstalk with other signal transduction pathways [Radtke
and Raj, 2003].We need first to address the role of Notch
signaling in the normal prostate gland before we can
understand its role in the initiation and progression of
prostate cancer and the functional consequences of
crosstalk with AR pathways. To do so, animal models
with prostate-specific ablation of different components of
the Notch pathway will be invaluable tools. This
knowledge should provide new insights into the biology
of prostate cancer and the possible involvement of Notch
signaling in the communication between AR-positive and
AR-negative cells within prostate tumors.Growing
evidences for a link between NRs and Notch signaling
pathwaysRecent work has implicated Notch signaling in
another endocrine cancer, namely hormone responsive
breast cancer. Thus, estrogens can increase the
expression of JAGGED1 and NOTCH1 in breast cancer
cells and this activation seems to be mediated, at least
in part, by estrogen-responsive elements present in their
promoters. It has been proposed that estrogen-dependent
activation of Notch signaling plays a role in the regulation
of angiogenic processes [Soares et al., 2004]. In addition,
a clinical study has described high level coexpression of
JAGGED1 and NOTCH1 in human breast cancer that is
associated with poor overall patient survival [Reedijk et
al., 2005], reinforcing the possibility that Notch signaling
is important for tumor progression in estrogen-dependent
tissues.
Conclusion
Crosstalk between NRs and Notch signaling pathways
seems to constitute one of the mechanisms by which
organisms integrate long distance endocrine signals with
cell-to-cell communication between adjacent cells helping
to build up the complexity required in higher eukaryotic
organisms.We predict that more examples of coordinated
action of these two signaling pathways will be uncovered
in the near future. The elucidation of the molecular
mechanisms responsible for the crosstalk between Notch
pathways and NRs will provide insights into many
physiological processes that are subject to regulation by
endogenous ligands. Pharmacological antagonists are
widely used for the treatment of endocrine cancers such
as breast and prostate cancer. The examples mentioned
above in which Notch signaling and NRs modulate their
activities in a reciprocal way with potential implications
for the appearance of androgen-independent prostate
cancer, the prognosis of estrogen-dependent breast
tumors or the regulation of angiogenic processes suggest
that the identification of the detailed molecular
mechanisms of interference between NR and Notch
pathways might help us to develop novel therapeutic
strategies for endocrine cancers.
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